← All organizations

Immunomedics

For profitWebsite ↗

Also known as: Immunomedics, Inc. | IMMUNOMEDICS INC

Highest phase reached

Phase 3

First clinical trial

Mar 1, 1997

First marketed drug

Apr 22, 2020

Last known activity

Jan 1, 2021

Acquired by Gilead Sciences on Sep 14, 2020

Timeline

1980s

  1. Jan 1, 1982

    Immunomedics— Founded

2020s

  1. Apr 22, 2020

    sacituzumab govitecan— Marketing Organization

  2. Sep 14, 2020

    Gilead Sciences— Acquired By

Drugs by trial phase (29 distinct, 55 trials)

Indications

Marketed drugs (1)

Recent trials (50)

Details

Founded
Morris Plains, NJ, US Jan 1, 1982
Last known activity
Jan 1, 2021